The US ambulatory electrocardiography monitoring device market will continue to experience growth after recovering from the impact of the COVID-19 pandemic. The market will be driven by recent reimbursement decisions, a heightened interest in remote monitoring services, promising results of clinical trials, and technological developments.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for ambulatory electrocardiography monitoring devices in the US from 2019 through 2032.
The adoption of longer-term monitoring is playing a critical role in the market.
How are policies evolving to accommodate the adoption of longer-term monitoring?
How will the adoption of longer-term monitoring influence the market share dynamics of competitors in this market?
What implications will this trend have for other types of ambulatory electrocardiography monitoring devices?
Technological advancements are changing the ambulatory electrocardiography monitoring device market.
Which types of companies stand to gain the most from technological advancements in this field?
Which notable approvals have been granted by the US FDA in this market?
How do algorithms contribute to improving patient care and outcomes?
Which specific types of innovations provide the most significant competitive advantage?
What competing technologies have recently entered the market?
Clinical evidence is supporting the market.
Which expanded indications will emerge as a result of clinical trials?
How do favorable trial results influence the distribution and adoption of devices within the market?
- Ambulatory Electrocardiography Monitoring Devices - Market Insights - United States
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Ambulatory Electrocardiography Monitoring Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Ambulatory ECG Monitoring Device Prescriptions, by Product Type, US, 2019u20132032
- Ambulatory ECG Monitoring Device Market Revenue, by Product Type, US (USD), 2019u20132032
- Ambulatory ECG Monitoring Device Prescriptions, by Prescription Type, US, 2019u20132032
- Ambulatory ECG Monitoring Device Prescriptions, by Indication, US, 2019u20132032
- Ambulatory ECG Monitoring Device Prescriptions, by Site of Service, US, 2019u20132032
- Market Shares
- Competitive Insights
- Market Developments
- Holter Monitor Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Holter Monitor Prescriptions, by Product Feature, US, 2019u20132032
- Holter Monitor Market Revenue, by Product Feature, US (USD), 2019u20132032
- Holter Monitor Prescriptions, by Prescription Type, US, 2019u20132032
- Holter Monitor Prescriptions, by Indication, US, 2019u20132032
- Holter Monitor Prescriptions, by Site of Service, US, 2019u20132032
- Short-Term Holter Monitor Prescriptions, by Prescription Type, US, 2019u20132032
- Short-Term Holter Monitor Prescriptions, by Indication, US, 2019u20132032
- Short-Term Holter Monitor Prescriptions, by Site of Service, US, 2019u20132032
- Long-Term Holter Monitor Prescriptions, by Indication, US, 2019u20132032
- Long-Term Holter Monitor Prescriptions, by Site of Service, US, 2019u20132032
- Market Shares
- Competitive Insights
- Event Recorder Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Event Recorder Prescriptions, by Prescription Type, US, 2019u20132032
- Event Recorder Prescriptions, by Indication, US, 2019u20132032
- Event Recorder Prescriptions, by Site of Service, US, 2019u20132032
- Event Recorder Market Revenue, US (USD), 2019u20132032
- Market Shares
- Competitive Insights
- Mobile Cardiac Telemetry Device Market
- Insertable Cardiac Monitor Market
- Appendix
Zsuzsa Lindenmaier
Zsuzsa Lindenmaier is an analyst on the Cardiovascular Medtech Insights team at Clarivate. Zsuzsa holds a Bachelor’s of Science in Neuroscience from the University of Florida and is a PhD candidate in the Department of Medical Biophysics at the University of Toronto.